What's Happening?
Made Scientific has inaugurated a new 60,000 sq. ft. GMP manufacturing facility in Princeton, New Jersey, marking a significant milestone in cell therapy manufacturing. The event was attended by New Jersey officials, including Governor Phil Murphy, who emphasized the state's leadership in life sciences and biomanufacturing. The facility represents a $12 million investment in infrastructure and technology, aimed at supporting the development and manufacturing of cell therapies. The company plans to expand further, adding 12,000 sq. ft. of GMP cleanroom space to increase production capacity.
AD
Why It's Important?
The opening of Made Scientific's facility is a pivotal development in the U.S. cell therapy sector, enhancing New Jersey's role as a hub for biomanufacturing innovation. This facility is expected to create high-quality jobs and contribute to the advancement of life-saving therapies. The investment underscores the growing importance of cell therapy in healthcare, with potential benefits for patients worldwide. It also highlights the strategic importance of New Jersey in attracting biotech companies and fostering an innovation-driven economy.
What's Next?
Made Scientific plans to expand its facility further, increasing its GMP manufacturing capacity to support late-phase and commercial programs. This expansion will enhance the company's ability to produce cell therapies at scale, meeting U.S. FDA and EU compliance standards. The company is expected to hire over 100 skilled professionals, strengthening its workforce and industry influence. This growth aligns with Made Scientific's mission to support the next generation of cell therapy innovators.
